Abstract
Lipase inhibitors are drugs used to reduce the activity of lipase found in the intestine. These inhibitors are used for the treatment of obesity and cardiovascular diseases. The purpose of this work was to explore in vitro the enzymatic and antioxidant activities of secondary metabolites extracts such as, phenolic compounds, flavonoids and tannins obtained with various extraction solvent systems: methanol/water, acetone/water and methanol/acetone/water from the aerial parts of five medicinal Algerian plants: Thymus algeriensis, Zygophyllum album, Thymus sepyllum, Marrubium vulgare L and Echium vulgare L. The lipase inhibition by these extracts described here has been for the first time. The results have shown a potent inhibitor, activity of lipase in acetone/water extraction mixture with ethyl acetate and butanol fractions from Thymus sepyllum and in methanol/acetone/water extraction mixture with ethyl acetate fraction from Marrubium vulgare L. The evaluation of antioxidant capacity was achieved by three chemical tests DPPH, Phosphomolybdenum and ABTS showing that our extracts possess potential antioxidant activities compared to standards.
Keywords: Antioxidant activities, Candida rugosa lipase inhibition, Echium vulgare L, Marrubium vulgare L, Thymus algeriensis, Thymus sepyllum, Zygophyllum album.
Current Enzyme Inhibition
Title:Inhibition of Candida rugosa Lipase by Different Extracts of Five Algerian Plants and their Antioxidant Activities
Volume: 10 Issue: 2
Author(s): Madjda Benguechoua, Samira Nia, Khedidja Benarous, Ihcen Khachba and Mohammed Yousfi
Affiliation:
Keywords: Antioxidant activities, Candida rugosa lipase inhibition, Echium vulgare L, Marrubium vulgare L, Thymus algeriensis, Thymus sepyllum, Zygophyllum album.
Abstract: Lipase inhibitors are drugs used to reduce the activity of lipase found in the intestine. These inhibitors are used for the treatment of obesity and cardiovascular diseases. The purpose of this work was to explore in vitro the enzymatic and antioxidant activities of secondary metabolites extracts such as, phenolic compounds, flavonoids and tannins obtained with various extraction solvent systems: methanol/water, acetone/water and methanol/acetone/water from the aerial parts of five medicinal Algerian plants: Thymus algeriensis, Zygophyllum album, Thymus sepyllum, Marrubium vulgare L and Echium vulgare L. The lipase inhibition by these extracts described here has been for the first time. The results have shown a potent inhibitor, activity of lipase in acetone/water extraction mixture with ethyl acetate and butanol fractions from Thymus sepyllum and in methanol/acetone/water extraction mixture with ethyl acetate fraction from Marrubium vulgare L. The evaluation of antioxidant capacity was achieved by three chemical tests DPPH, Phosphomolybdenum and ABTS showing that our extracts possess potential antioxidant activities compared to standards.
Export Options
About this article
Cite this article as:
Benguechoua Madjda, Nia Samira, Benarous Khedidja, Khachba Ihcen and Yousfi Mohammed, Inhibition of Candida rugosa Lipase by Different Extracts of Five Algerian Plants and their Antioxidant Activities, Current Enzyme Inhibition 2014; 10 (2) . https://dx.doi.org/10.2174/1573408010666140812233628
DOI https://dx.doi.org/10.2174/1573408010666140812233628 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atypical Chest Pain in ACS: A Trap Especially for Women
Current Pharmaceutical Design Autologous Cell Therapy for Vascular Regeneration: The Role of Proangiogenic Cells
Current Medicinal Chemistry Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Editorial (Hot Topic :Advances in Industry for Chronic Respiratory Diseases)
Inflammation & Allergy - Drug Targets (Discontinued) Disruption of Circadian Rhythms and Sleep on Critical Illness and the Impact on Cardiovascular Events
Current Pharmaceutical Design Pleiotropic Effects of ARB in Vascular Metabolism - Focusing on Atherosclerosis-Based Cardiovascular Disease
Current Vascular Pharmacology Therapeutic Targeting of HDL and Reverse Cholesterol Transport
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Is Mental Practice an Effective Adjunct Therapeutic Strategy for Upper Limb Motor Restoration After Stroke? A Systematic Review and Meta- Analysis
CNS & Neurological Disorders - Drug Targets The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Flow and Microwave Assisted Synthesis of Medicinally Relevant Indoles
Current Green Chemistry Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design Intimal Hyperplasia in Murine Models
Current Drug Targets Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Current Neuropharmacology Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Current Medicinal Chemistry Recent Advances on Detection of Modified Forms of Low-Density Lipoproteins
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Enzyme Inhibitors
Current Bioactive Compounds Agents for the Inhibition of Cholesteryl Ester Transfer Protein (CETP) and Prospects for the Future Treatment of Atherosclerosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and LDopa Treatment
Current Genomics Azimilide, A Novel Oral Class III Antiarrhythmic for Both Supraventricular and Ventricular Arrhythmias
Current Drug Targets - Cardiovascular & Hematological Disorders